YOU SEARCHED BY...
SEARCH BY...
Contract Service Directory
Country
- Argentina(1)
- Australia(7)
- Austria(1)
- Belgium(3)
- Canada(52)
- China(17)
- Denmark(2)
- Finland(1)
- France(13)
- Germany(36)
- Greece(2)
- Hong Kong(1)
- Hungary(2)
- India(68)
- Ireland(1)
- Israel(3)
- Italia (5)
- Japan(1)
- Latvia(1)
- Luxembourg(1)
- Mexico(2)
- New Zealand(1)
- Peru(1)
- Poland(1)
- Portugal(3)
- Romania(1)
- Singapore(1)
- Slovenia(2)
- South Korea(6)
- Spain(11)
- Sweden(3)
- Switzerland(22)
- Taiwan(2)
- The Czech Republic(1)
- The Netherlands(5)
- Turkey(2)
- Ukraine(1)
- United Kingdom(48)
- United States(635)
- Vietnam(1)
Contract Service Directory
Denison Pharmaceuticals
Company Headquarters
1 Powder Hill Road
Lincoln, RI 02865
United States
Contract Service Directory
- Analytical Laboratory Services
- Contract Development and Manufacturing Organization (CDMO)
- Contract Manufacturing
- Formulation Development
- Formulation Services
- Manufacturing, Creams & Ointments
- Manufacturing, Custom
- Manufacturing, Gels
- Manufacturing, Liquids
- Manufacturing, OTC
- Manufacturing, Semisolids
- Manufacturing, Solutions & Suspensions
- Methods Development
- Packaging, Creams & Ointments
- Packaging, OTC
Related Content
-
-
Bio News | cGMP Manufacture | Facilities | Industry News | Inspections
GRAM Completes Successful FDA Inspection
Following eight day inspection, GRAM was found to be in compliance with cGMP, with no Form 483 observations issued11.09.18
-
Breaking News | Industry News | Promotions & Moves
PPD Adds New Therapeutic Area Professionals
Expands experience in neuroscience, hematology/oncology, rare diseases and pediatrics11.01.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
AbbVie Takes Over Galapagos Collaboration
Will assume full development & commercial responsibility for its collaboration with Galapagos for cystic fibrosis treatments10.25.18
-
Breaking News | Drug Development | Industry News | Trials & Filings
Genentech's XOFLUZA Wins FDA Approval
Single-dose oral medicine demonstrates efficacy against a wide range of influenza viruses10.25.18
-
Breaking News | Capsules | Collaborations & Alliances | Packaging & Tracking
PCI, CSP Technologies in Exclusive Activ-Blister Alliance
To provide clinical trials and stability testing utilizing Activ-Blister packaging solutions09.17.18
-
APIs | Cytotoxics and High Potency Manufacturing
HPAPI Market Trends
Rising demand for targeted cancer and other treatments driving HPAPI growth.Nigel Walker, That’s Nice/Nice Insight 09.11.18
-
Finding the Right Partner
Join Contract Pharma as it hosts its 17th Contracting & Outsourcing event Sept. 27-28Tim Wright, Editor 09.11.18
-
Bio News | Industry News | Promotions & Moves
Retrophin Appoints CMO
Dr. Noah L. Rosenberg joins the company with 20 years industry experience07.31.18
-
-
Bio News | Breaking News | Drug Development | Industry News
Otsuka Buying Visterra for $430M
Hierotope platform enables design and engineering of next-generation antibody-based therapies07.12.18
-
Biosimilars
Navigating Uncertainty in Biosimilar Drug Development
Bryan Katz of Syneos Health and Brittany Scott of Addison Whitney share insights from DIABryan Katz, Vice President Integrated Solutions, Syneos Health and Brittany Scott, Creative Director, Addison Whitney, a Syneos Health company 07.11.18
-
Industry News
Sanofi Sells European Generics Biz
To focus on core areas of global medicines and emerging markets, specialty care and diabetes and cardiovascular06.29.18
-
Regulatory Affairs | Solid Dosage/Creams/Ointments
Semi-Solids: A Regulatory Perspective
Compliance of semi-solid dosages to FDA Stage III Continuous Process Verification.José L. Toro, Ph.D., Lachman Consultants 06.12.18
-
The Salary Survey & Much More
From surveys, to drug development & delivery to compliance, the June issue covers a lot of ground06.12.18
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Vectalys, Flashcell Merge to Form New Gene Therapy Company
Flash Therapeutics to develop RNA-based therapeutics and provide broad lentiviral development and manufacturing services05.18.18
